Nyowani US Patent yeKuona PTSD muZvidzidzo Zvekurarama

rakanyorwa mupepeti

Neurovation Labs, Inc., kambani yebiotech yakanangana nemuviri wePTSD kuti uongorore uye kurapwa, nhasi yazivisa kuti US Patent uye Trademark Hofisi yakapa US Patent Nhamba 11,224,668, muna Ndira 18, 2022.

Print Friendly, PDF & Email

Patent, ine musoro unoti "Compositions and Methods to Detect GluA1 in Brain and to Identify the Presence of GluA1-Mediated PTSD," yakanangidzirwa kune zvinyorwa zvitsva uye nzira dzekuongorora PTSD pamwe nekurapa PTSD mushure mekuongororwa kwakadaro.              

"Mushonga unochengetedzwa nemvumo iyi unobva kune imwe yemakirasi akatevedzana ari kugadzirwa neNeurovation Labs kuti igone kuvhenekwa nechinangwa chePTSD uye kuongorora zviri nani nzira dziri pasi pePTSD uye kumwe kusagadzikana kwehutano hwepfungwa. Mishonga iyi uye nzira dzinoenderana dzakafukidzwa nemvumo inomiririra chinyorwa, nzira yakanangwa yehutano hwepfungwa uye kuona kuvhiringidzika kwehuropi, "akadaro Dr. Jennifer Perusini, Co-Founder & Chief Executive Officer wekambani.

Patent iyi ndeye Neurovation Labs chete uye ndiyo yekutanga kuburitswa kubva kune yakafaranuka pfuma portfolio kubva mukutsvagisa nekusimudzira kwekambani.

Print Friendly, PDF & Email

Nezvomunyori

mupepeti

Mupepeti mukuru we eTurboNew ndiLinda Hohnholz. Iye anogara muTN HQ muHonolulu, Hawaii.

Leave a Comment